The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bitsadze V.O.

Sechenov First Moscow State Medical University, Moscow, Russia

Bredikhin R.A.

Interregional Clinical Diagnostic Center;
Kazan State Medical University

Bulatov V.L.

Institute of Experimental Medicine

Golovina V.I.

Pirogov Russian National Research Medical University

Dzhenina O.V.

First Phlebology Center, Moscow, Russia

Zolotukhin I.A.

Pirogov Russian National Research Medical University

Ilyukhin E.A.

Surgical clinic Medalp

Kalinin R.E.

Ryazan State Medical University

Katorkin S.E.

Samarskiĭ gosudarstvennyĭ meditsinskiĭ universitet

Kirienko A.I.

Pirogov Russian National Research Medical University

Krylov A.Yu.

Sechenov First Moscow State Medical University

Lobastov K.V.

Pirogov Russian National Research Medical University

Makatsaria A.D.

Sechenov First Moscow State Medical University, Moscow, Russia

Mzhavanadze N.D.

Pavlov Ryazan State Medical University

Porembskaya O.Ya.

Mechnikov North-Western State Medical University;
Institute of Experimental Medicine

Priadko S.I.

Nauchnyĭ tsentr serdechno-sosudistoĭ khirurgii im. A.N. Bakuleva RAMN, Moskva;
Institut bioorganicheskoĭ khimii im. M.M. Shemiakina i Iu.A. Ovchinnikova, Moskva

Seliverstov E.I.

Pirogov Russian National Research Medical University

Sonkin I.N.

Road Clinical Hospital of Russian Railways

Soroka V.V.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Stoyko Yu.M.

N.I. Pirogov National Medical and Surgical Center

Suchkov I.A.

Ryazan State Medical University

Schastlivtsev I.V.

Pirogov’s Russian National Research Medical University

Cherkashin M.A.

Treatment and Diagnostic Center of the Berezina International Institute of Biological Systems

Superficial phlebitis and thrombophlebitis

Authors:

Bitsadze V.O., Bredikhin R.A., Bulatov V.L., Golovina V.I., Dzhenina O.V., Zolotukhin I.A., Ilyukhin E.A., Kalinin R.E., Katorkin S.E., Kirienko A.I., Krylov A.Yu., Lobastov K.V., Makatsaria A.D., Mzhavanadze N.D., Porembskaya O.Ya., Priadko S.I., Seliverstov E.I., Sonkin I.N., Soroka V.V., Stoyko Yu.M., Suchkov I.A., Schastlivtsev I.V., Cherkashin M.A.

More about the authors

Journal: Journal of Venous Disorders. 2021;15(3): 211‑244

DOI: 10.17116/flebo202115031211

Read: 13652 times

Download PDF (RU)
Contact the author
Table of contents

SUPERFICIAL PHLEBITIS AND THROMBOPHLEBITIS
SUPERFICIAL PHLEBITIS AND THROMBOPHLEBITIS

To cite this article:

Bitsadze VO, Bredikhin RA, Bulatov VL, et al. . Superficial phlebitis and thrombophlebitis. Journal of Venous Disorders. 2021;15(3):211‑244. (In Russ.)
https://doi.org/10.17116/flebo202115031211

Подписка 2026 Флебология (Journal of Venous Disorders)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

International Statistical Classification of Diseases and Related Health Problems coding: I80.0, I80.8, I82.1, O22.2, O87.0

Year of approval (frequency of revision): 2021 (revision every 4 years)

Age category: Adults

Developers of the clinical guidelines: Association of Phlebologists of Russia; Association of Cardiovascular Surgeons of Russia; Russian Society of Surgeons; Russian Society of Angiologists and Vascular Surgeons

Authors:

Bitsadze V.O.

Sechenov First Moscow State Medical University, Moscow, Russia

Bredikhin R.A.

Interregional Clinical Diagnostic Center;
Kazan State Medical University

Bulatov V.L.

Institute of Experimental Medicine

Golovina V.I.

Pirogov Russian National Research Medical University

Dzhenina O.V.

First Phlebology Center, Moscow, Russia

Zolotukhin I.A.

Pirogov Russian National Research Medical University

Ilyukhin E.A.

Surgical clinic Medalp

Kalinin R.E.

Ryazan State Medical University

Katorkin S.E.

Samarskiĭ gosudarstvennyĭ meditsinskiĭ universitet

Kirienko A.I.

Pirogov Russian National Research Medical University

Krylov A.Yu.

Sechenov First Moscow State Medical University

Lobastov K.V.

Pirogov Russian National Research Medical University

Makatsaria A.D.

Sechenov First Moscow State Medical University, Moscow, Russia

Mzhavanadze N.D.

Pavlov Ryazan State Medical University

Porembskaya O.Ya.

Mechnikov North-Western State Medical University;
Institute of Experimental Medicine

Priadko S.I.

Nauchnyĭ tsentr serdechno-sosudistoĭ khirurgii im. A.N. Bakuleva RAMN, Moskva;
Institut bioorganicheskoĭ khimii im. M.M. Shemiakina i Iu.A. Ovchinnikova, Moskva

Seliverstov E.I.

Pirogov Russian National Research Medical University

Sonkin I.N.

Road Clinical Hospital of Russian Railways

Soroka V.V.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Stoyko Yu.M.

N.I. Pirogov National Medical and Surgical Center

Suchkov I.A.

Ryazan State Medical University

Schastlivtsev I.V.

Pirogov’s Russian National Research Medical University

Cherkashin M.A.

Treatment and Diagnostic Center of the Berezina International Institute of Biological Systems

Close metadata

References:

  1. Meissner MH, Wakefield TW, Ascher E, Caprini JA, Comerota AJ, Eklof B, Gillespie DL, Greenfield LJ, He AR, Henke PK, Hingorani A, Hull RD, Kessler CM, McBane RD, McLafferty R. Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg. 2007;46(suppl S):25-53. 
  2. Gillet JL, Perrin M, Cayman R. Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients (Article in French). J Mal Vasc. 2001;26:1:16-22. 
  3. Leon L, Giannoukas AD, Dodd D, Chan P, Labropoulos N. Clinical Significance of Superficial Vein Thrombosis. Eur J Vasc Endovasc Surg. 2005;29:1:10-17. 
  4. Blättler, Schwarzenbach, Largiadèr. Superficial vein thrombophlebitis—serious concern or much ado about little? VASA. 2008;37:1:31-38. 
  5. Decousus H, Frappé P, Accassat S, Bertoletti L, Buchmuller A, Seffert B, Merah A, Becker F, Queré I, Leizorovicz A. Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs. Best Pr Res Clin Haematol. 2012;25:3:275-284. 
  6. Saveliev VS, Kirienko AI, Zolotukhin IA, Seliverstov EI. Prospective observational study SPEKTR: registry of patients with chronic vein diseases of the lower extremities. Phlebology. 2012;6:1:4-9.  (In Russ.).
  7. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost England. 2008;6:6:905-912. 
  8. Barrellier MT. Superficial venous thromboses of the legs (Article in French). Phlebologie. France. 1993;46:4:633-639. 
  9. Krause U, Kock HJ, Kröger K, Albrecht K, Rudofsky G. Prevention of deep venous thrombosis associated with superficial thrombophlebitis of the leg by early saphenous vein ligation. VASA. Switzerland. 1998;27:1:34-38. 
  10. Mouton WG, Kienle Y, Muggli B, Naef M, Wagner HE. Tumors associated with superficial thrombophlebitis. VASA. Switzerland. 2009;38:2:167-170. 
  11. Engesser L, Broekmans AW, Briët E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern. Med United States. 1987;106:5:677-682. 
  12. Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. Arter Thromb Vasc Biol. United States. 1996;16:6:742-748. 
  13. Karathanos C, Spanos K, Saleptsis V, Tsezou A, Kyriakou D, Giannoukas AD. Recurrence of superficial vein thrombosis in patients with varicose veins. Phlebology. England. 2016;31:7:489-495. 
  14. de Moerloose P, Wutschert R, Heinzmann M, Perneger T, Reber G, Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost. 1998;80:2:239-241. 
  15. Hanson JN, Ascher E, DePippo P, Lorensen E, Scheinman M, Yorkovich W, Hingorani A. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease. J Vasc Surg. 1998;27:4:677-680. 
  16. Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM. Genetic risk factors for superficial vein thrombosis. Thromb Haemost. 1999;82:4:1215-1217.
  17. Schönauer V, Kyrle PA, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Partsch H, Eichinger S. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg. United States. 2003;37:4:834-838. 
  18. de Godoy JMP, Braile DM. Protein S deficiency in repetitive superficial thrombophlebitis. Clin Appl Thromb Hemost. United States. 2003;9:1:61-62. 
  19. van Langevelde K, Lijfering WM, Rosendaal FR, Cannegieter SC. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. Blood. United States. 2011;118:15:4239-4241.
  20. Legnani C, Cini M, Cosmi B, Filippini M, Favaretto E, Palareti G. Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs. Thromb Haemost. Germany. 2014;111:6:1194-1196.
  21. Karathanos C, Exarchou M, Tsezou A, Kyriakou D, Wittens C, Giannoukas A. Factors associated with the development of superficial vein thrombosis in patients with varicose veins. Thromb Res. United States. 2013;132:1:47-50. 
  22. de Godoy JM, Batigália F, Braile DM. Superficial thrombophlebitis and anticardiolipin antibodies--report of association. Angiology. 2001;52:2:127-129. 
  23. Di Minno MND, Ambrosino P, Ambrosini F, Tremoli E, Di Minno G, Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost. 2016;14:5:964-972. 
  24. Chengelis DL, Bendick PJ, Glover JL, Brown OW, Ranval TJ. Progression of superficial venous thrombosis to deep vein thrombosis. J Vasc Surg. 1996;24:5:745-749. 
  25. Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg. 1998;27:2:338-343. 
  26. Dalsing MC. The Case Against Anticoagulation for Superficial Venous Thrombosis. Dis Mon. 2010;56:10:582-589. 
  27. Leizorovicz A, Becker F, Buchmüller A, Quéré I, Prandoni P, Decousus H. Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood. 2013;122:10:1724-1729.
  28. Gavrilov S, Zolotkhin I, Pustovoit A. Ligation of the main saphenous vein for acute ascending thrombophlebitis. Phlebology. 2011;5:4:88-90. (In Russ.).
  29. Frappé P, Buchmuller-Cordier A, Bertoletti L, Bonithon-Kopp C, Couzan S, Lafond P, Leizorovicz A, Merah A, Presles E, Preynat P, Tardy B, Décousus H, STEPH Study Group. Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study. J Thromb Haemost. 2014;12:6:831-838. 
  30. Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. United States. 1973;48:4:839-846. 
  31. Superficial thrombophlebitis. Handb. Venous Lymphat. Disord. 4th ed. ed. Gloviczki P. CRC Press. 2017;343-347. 
  32. Lutter KS, Kerr TM, Roedersheimer LR, Lohr JM, Sampson MG, Cranley JJ. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery. 1991;110:1:42-46. 
  33. Decousus H, Quéré I, Presles E, Becker F, Barrellier M-T, Chanut M, Gillet J-L, Guenneguez H, Leandri C, Mismetti P, Pichot O, Leizorovicz A. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010;152:4:218-224. 
  34. Kudlaty E, Oriowo B, Yang MJ, Go MR, Satiani B. Isolated Great Saphenous Vein Thrombus Is Associated with High Rates of Complications regardless of Management. Ann Vasc Surg. 2017;45:154-159. 
  35. Binder B, Lackner HK, Salmhofer W, Kroemer S, Custovic J, Hofmann-Wellenhof R. Association between superficial vein thrombosis and deep vein thrombosis of the lower extremities. Arch Dermatol. 2009;145:7:753-757. 
  36. Galanaud JP, Genty C, Sevestre MA, Brisot D, Lausecker M, Gillet JL, Rolland C, Righini M, Leftheriotis G, Bosson JL, Quere I. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis: The OPTIMEV study. Thromb Haemost. 2011;105:1:31-39. 
  37. Cannegieter SC, Horváth-Puhó E, Schmidt M, Dekkers OM, Pedersen L, Vandenbroucke JP, Sørensen HT. Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: A nationwide cohort study. Blood American Society of Hematology. 2015;125:2:229-235. 
  38. Galanaud JP, Bosson JL, Genty C., Presles E. Superficial vein thrombosis and recurrent venous thromboembolism : a pooled analysis of two observational studies. J Thromb Haemost. 2012;1004-1011.
  39. Quenet S, Laporte S, Décousus H, Leizorovicz A, Epinat M, Mismetti P. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis. J Vasc Surg Mosby Inc. 2003;38:5:944-949. 
  40. Кириенко А., Матюшенко А., Андрияшкин В. Острый тромбофлебит. ЛитТерра. 2006;109. 
  41. Marković MD, Lotina SI, Davidović LB, Vojnović BR, Kostić DM, Cinara IS, Svetković SD. Acute superficial thrombophlebitis — modern diagnosis and therapy. (Article in Serbian). Srp Arh Celok Lek. 125;9-10:261-266. 
  42. Bauersachs RM. Diagnosis and treatment of superficial vein thrombosis. Hamostaseologie. 2013;33:3:232-240. 
  43. Nasr H, Scriven JM. Superficial thrombophlebitis (superficial venous thrombosis). BMJ. 2015;350:h2039.
  44. Stoyko YM, Kirienko AI, Ilyukhin EA, Lobastov KV, Chabbarov RG, Parikov MA, Khorev NG, Zolotukhin IA, Andriashkin VV, Karpenko AA, Fokin AA, Sushkov SA, Sapelkin SV, Suchkov IA, Krylov AA, Ignatiev IM. Diagnosis and treatment of thrombophlebitis of superficial limb veins. Recommendations of the Russian Phlebologists Association. Phlebology. 2019;13:2:78-97.  (In Russ.).
  45. Shevchenko YL., Stoyko YM. Clinical phlebology. DPC Press. 2016;256.  (In Russ.).
  46. Saveliev VS, Gologorsky VA, Kirienko AI, Alekperova TV, Andriashkin VV, Bogachev VY, Bogdanets LI, Virgansky AO, Gelfand BR, Gologorsky VA, Grigoryan RA, Grinenko TF, Zolotukhin IA, Kapranov SA, Leontiev SG, Matyushenko AA, Prokubovsky VI. Phlebology: a guide for doctors. M: Medicine, 2001. 664 p.  (In Russ.).
  47. Caprini, Goldshteyn, Glase, Hathaway. Thrombophilia testing in patients with venous thrombosis. Eur J Vasc Endovasc Surg. Eur J Vasc Endovasc Surg. 2005;30:5:550-555. 
  48. Karathanos C, Sfyroeras G, Drakou A, Roussas N, Exarchou M, Kyriakou D, Giannoukas A. Superficial vein thrombosis in patients with varicose veins: role of thrombophilia factors, age and body mass. Eur J Vasc Endovasc Surg. Eur J Vasc Endovasc Surg. 2012;43:3:355-358. 
  49. Kalodiki E, Stvrtinova V, Allegra C, Andreozzi G, Antignani PL, Avram R, Brkljacic B, Cadariou F, Dzsinich C, Fareed J. Superficial vein thrombosis: a consensus statement. Int Angiol. 2012;31:3:203-216. 
  50. Zygmunt JA. Duplex ultrasound for chronic venous insufficiency. J Invasive Cardiol. 2014;26:11:149-155. 
  51. Smith ZT, Bagley AR, Guy D, Preston L, Ali NS. Ultrasound Imaging of Superficial Venous Thrombosis in the Upper and Lower Extremities: Closing the Gap Between Clinical Management Guidelines and Ultrasound Practice Parameters. J Ultrasound Med. 2021;1-8. 
  52. Madhusudhana S, Moore A, Moormeier JA. Current issues in the diagnosis and management of deep vein thrombosis. Mo Med. 2009;106:1:43-48. 
  53. Lim KE, Hsu WC, Hsu YY, Chu PH, Ng CJ. Deep venous thrombosis: Comparison of indirect multidetector CT venography and sonography of lower extremities in 26 patients. Clin Imaging. Elsevier Inc. 2004;28:6:439-444. 
  54. Maki DD, Kumar N, Nguyen B, Langer JE, Miller J, Gefter WB. Distribution of thrombi in acute lower extremity deep venous thrombosis: Implications for sonography and CT and MR venography. AJR Am J Roentgenol. American Roentgen Ray Society. 2000;175:5:1299-1301.
  55. Carpenter J, Holland G, Baum R, Owen R, Carpenter J, Cope C. Magnetic resonance venography for the detection of deep venous thrombosis: comparison with contrast venography and duplex Doppler ultrasonography. J Vasc Surg. J Vasc Surg. 1993;18:5:734-741. 
  56. Duwe K, Shiau M, Budorick N, Austin J, Berkmen Y. Evaluation of the lower extremity veins in patients with suspected pulmonary embolism: a retrospective comparison of helical CT venography and sonography. 2000 ARRS Executive Council Award I. American Roentgen Ray Society. AJR Am J Roentgenol. AJR Am J Roentgenol. 2000;175:6:1525-1531.
  57. Ilyukhin EA, Demekhova MY, Shonov OA, Zolotukhin IA. Individual assessment of benefits and risks of secondary prevention of venous thromboembolic complications by anticoagulants. Phlebology. 2014;4:8:42-54.  (In Russ.).
  58. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. Elsevier Ltd. 2016;149:2:315-352. 
  59. Uncu H. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis. Phlebology. 2009;24:2:56-60. 
  60. The Superficial Thrombophlebitis Treated by Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med. 2003;163:14:1657-1663.
  61. Cesarone MR, et al. Management of Superficial Vein Thrombosis and Thrombophlebitis: Status and Expert Opinion Document. Angiology. 2007; 58:1S:7--14. 
  62. Maeseneer MGR. De. Superficial Thrombophlebitis of the Lower Limb : Practical Recommendations for Diagnosis and Treatment Superficial Thrombophlebitis of the Lower Limb : Practical Recommendations. Acta Chir Belg. 2016;145-147. 
  63. Sharma A. Effectiveness of Cold Application, Heparinoid Application and Megnesium-sulphate Application on Superficial Thrombophlebitis-Literature Review. Int J Nurs Educ Diva Enterprises Private Limited. 2016;8:2:1. 
  64. Sharma A. A comparative study to assess the effectiveness of cold application heparinoid application and magnesium sulphate application on superficial thrombophlebitis among patients admitted in selected hospital of Gujarat. Int J Nurs Educ. 2016;8:118-121. 
  65. Kirienko AI. Acute varicotrombophlebitis: diagnosis, basic principles of treatment and prevention. RMJ. 1999;13:600.  (In Russ.).
  66. Quenet S, Laroche L, Bertoletti L, Quéré I, Décousus H, Becker F, Leizorovicz A. Value of a Planned Compression Ultrasonography after an Isolated Superficial Vein Thrombosis: Results from a Prospective Multicentre Study. Eur J Vasc Endovasc Surg. 2011;43:233-237. 
  67. Kakkos SK, et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg. W.B. Saunders Ltd. 2021;61:1:9-82. 
  68. Cosmi B. Management of superficial vein thrombosis. J Thromb Haemost. 2015;13:7:1175-1183.
  69. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. John Wiley and Sons Ltd. 2018;2:2:CD004982.
  70. Rathbun SW, Aston CE, Whitsett TL. A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. J Thromb Haemost. Blackwell Publishing Ltd. 2012;10:5:833-839. 
  71. Ferrari E, Pratesi C, Scaricabarozzi I. A comparison of nimesulide and diclofenac in the treatment of acute superficial thrombophlebitis. Drugs. 1993;46:1:197-199. 
  72. Agus GB, De Angelis R, Mondani P, Moia R. Double-blind comparison of nimesulide and diclofenac in the treatment of superficial thrombophlebitis with telethermographic assessment. Drugs. 1993;46:1:200-203. 
  73. Katzenschlager R, Hirschl M, Minar E, Ugurluoglu A. Liposomal heparin-spraygel in comparison with subcutaneous low molecular weight heparin in patients with superficial venous thrombosis. A randomized, controlled, open multicentre study. J fur Kardiol. 2003;10:9:375-378. 
  74. Becherucci A, Bagilet D, Marenghini J, Diab M, Biancardi H. Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion. (Article in Spanish). Med Clin. 2000;114:10:371-373. 
  75. Boehler K, Kittler H, Stolkovich S, Tzaneva S. Therapeutic Effect of Compression Stockings Versus no Compression on Isolated Superficial Vein Thrombosis of the Legs: A Randomized Clinical Trial. Eur J Vasc Endovasc Surg. Elsevier. 2014;48:4:465-471. 
  76. De Sanctis MT, Cesarone MR, Incandela L, Belcaro G, Griffin M. Treatment of Superficial Vein Thrombosis with Standardized Application of Essaven Gel Placebo-Controlled, Randomized Study. Angiology. 2001;52:3(suppl P):57-62. 
  77. Incandela L, De Sanctis MT, Cesarone MR, Ricci A, Errichi BM, Dugal M, Belcaro G, Griffin M. Treatment of superficial vein thrombosis: clinical evaluation of Essaven gel — a placebo-controlled, 8-week, randomized study. Angiology. United States. 2001;52(suppl 3)69-72. 
  78. No authors listed. Indomethacin in superficial thrombophlebitis. Practitioner. 1970/09/01. 1970;205:227:369-372. 
  79. Górski G, Szopiński P, Michalak J, Marianowska A, Borkowski M, Geremek M, Trochimczuk M, Brotánek J, Sárník S, Seménka J. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis. Angiology. 2005;56:1:9-17. 
  80. Villardell M, Sabat D, Arnaiz JA, Bleda MJ, Castel JM, Laporte JR, Vallvé C. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter A double-blind, randomized, placebo-controlled trial. Eur J Clin Pharmacol. 1999;54:12:917-921. 
  81. Bergqvist D, Brunkwall J, Jensen N, Persson NH. Treatment of superficial thrombophlebitis. A comparative trial between placebo, Hirudoid cream and piroxicam gel. Ann Chir Gynaecol. 1990;79:2:92-96. 
  82. Belcaro G, Cesarone MR, Dugall M, Feragalli B, Ippolito E, Corsi M, Hosoi M, Cornelli U, Ledda A, Gizzi G. Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. Panminerva Med. 2011;53:3(suppl 1):3-11. 
  83. Zolkin VN, Tischenko IS. Anticoagulant therapy in the treatment of acute thrombosis of deep and superficial veins of the lower extremities. Difficult Patient. 2007;5:15-16:11-15.  (In Russ.).
  84. Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010;363:13:1222-1232.
  85. Cosmi B, et al. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). J Thromb Haemost. 2012.
  86. The Vesalio Investigators G. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost. Blackwell Science Inc. 2005;3:6:1152-1157.
  87. Titon JP, Auger D, Grange P, Hecquet JP, Remond A, Ulliac P, Vaissie JJ. Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent. (Article in French). Ann Cardiol Angeiol. 1994/03/01. 1994;43:3:160-166. 
  88. Beyer-Westendorf J, Schellong SM, Gerlach H, Rabe E, Weitz JI, Jersemann K, Sahin K, Bauersachs R, SURPRISE investigators. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol. 2017;4:3:105-113. 
  89. Bokeria LA, Zatevakhin II, Kirienko AI. Russian clinical guidelines for diagnosis, treatment and prevention of venous thromboembolic complications. Phlebology. 2015;4:2:2-25.  (In Russ.).
  90. Sullivan V, Denk PM, Sonnad SS, Eagleton MJ, Wakefield TW. Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system. J Am Coll Surg. 2001;193:5:556-562. 
  91. Rohrbach N, Mouton W, Naef M, Otten K, Zehnder T, Wagner H. Morbidity in superficial thrombophlebitis and its potential surgical prevention. Swiss Surg. Swiss Surg. 2003;9:1:15-17. 
  92. Davidson, Verheijen, Lensing, Gebel, Brighton, Lyons, Rehm, Prins. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin. JAMA Intern Med. JAMA Intern Med. 2014;174:6:947-953. 
  93. Frohneck HS. Diseases of the Veins. Moscow: GEOTAR-Media, 2010. 208 p.  (In Russ.).
  94. Giannoukas A, Karathanos C, Nikolakopoulos K, Georgiadis GS, Maltezos C, Ioannou C, Vasdekis S, Trelopoulos G. Tinzaparin in intermediate dose for the treatment of superficial vein thrombosis: Results from an observational multicenter study-SeVEN study. Phlebology. England. 2018;33:9:636-645. 
  95. Quenet S, Laroche JP, Bertoletti L, Quéré I, Décousus H, Becker F, Leizorovicz A. Value of a planned compression ultrasonography after an isolated superficial vein thrombosis: Results from a prospective multicentre study. Eur J Vasc Endovasc Surg. 2012;43:2:233-237. 
  96. Wichers I, Di Nisio M, Büller H, Middeldorp S. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica. 2005;5:672-677. 
  97. Marchiori A, Verlato F, Sabbion P, Camporese G, Rosso F, Mosena L, Andreozzi GM, Prandoni P. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. Haematologica. 2002;87:5:523-527. 
  98. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. American College of Chest Physicians. 2012;141:2(suppl P):419-494. 
  99. Decousus H, Quéré I, Presles E, Becker F, Barrellier M-T, Chanut M, Gillet J-L, Guenneguez H, Leandri C, Mismetti P, Pichot O, Leizorovicz A. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010;152:4:218-224. 
  100. Cosmi B, Filippini M, Campana F, Avruscio G, Ghirarduzzi A, Bucherini E, Camporese G, Imberti D, Legnani C, Palareti G. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum). Thromb Res Elsevier Ltd. 2014;133:2:196-202. 
  101. Barco S, Pomero F, Di Minno MND, Tamborini Permunian E, Malato A, Pasca S, Barillari G, Fenoglio L, Siragusa S, Di Minno G, Ageno W, Dentali F. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study. J Thromb Haemost. England. 2017;15:11:2176-2183.
  102. Di Nisio M, Peinemann F, Porreca E, Rutjes AW. Treatment for superficial infusion thrombophlebitis of the upper extremity. Cochrane Database Syst Rev. Ed. Di Nisio M. Chichester, UK: John Wiley & Sons, Ltd; 2015.
  103. Lipe DN, Foris LA, King KC. Septic Thrombophlebitis. Septic Thrombophlebitis. Treasure Island (FL): StatPearls Publishing; 2020.
  104. Chirinos JA, Garcia J, Alcaide ML, Toledo G, Baracco GJ, Lichtstein DM. Septic thrombophlebitis: diagnosis and management. Am J Cardiovasc Drugs. 2006;6:1:9-14. 
  105. Yakovlev S, Zhuravleva M, Protsenko D, Beloborodov V, Brico N, Brusina E, Gusarov V, Eliseeva E, Zamyatin M, Zyryanov S. The SCAT (Strategy for Controlling Antimicrobial Therapy) Program in Inpatient Medical Care. Cons Medicum. 2017;19:7-1:15-51.  (In Russ.).
  106. Mezon BJ, Voitk AJ. Septic superficial thrombophlebitis: a major threat from a minor lesion. Can Med Assoc J. 1976;114:12:1128-1132.
  107. Andes DR, Urban AW, Acher CW, Maki DG. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter. Am J Med. 1998;105:5:446-450. 
  108. Mailhe M, Aubry C, Brouqui P, Michelet P, Raoult D, Parola P, Lagier JC. Complications of peripheral venous catheters: The need to propose an alternative route of administration. Int J Antimicrob Agents. Elsevier B.V. 2020;55:3. 
  109. Heit, Silverstein, Mohr, Petterson, O’Fallon, Melton. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. Arch Intern Med. 2000;160:6:809-815. 
  110. Bauersachs, Gerlach, Heinken, Hoffmann, Langer, Noppeney, Pittrow, Klotsche, Rabe. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT). Eur J Vasc Endovasc Surg. Eur J Vasc Endovasc Surg. 2021.
  111. Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, Vazquez SR, Greer IA, Riva JJ, Bhatt M, Schwab N, Barrett D, LaHaye A, Rochwerg B. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2:22:3317-3359.
  112. Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41:1:92-128. 
  113. Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. RCOG Green-top Guideline No. 37b [Electronic resource]. 2015. Accessed: 21.07.21.  https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37b
  114. Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk. RCOG Green-top Guideline No. 37a [Electronic resource]. 2015. Accessed: 24.07.21.  https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/
  115. Sukhikh GT. et al. Prevention of venous thromboembolic complications in obstetrics and gynecology. Clinical guidelines (protocol). Obstetrics and gynecology. 2014;10:1-18.  (In Russ.).
  116. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A-M, Vandvik PO. VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:2(suppl P):691-736. 
  117. Aaro, Johnson, Juergens. Acute superficial venous thrombophlebitis associated with pregnancy. Am J Obs. Gynecol. Am J Obstet Gynecol. 1967;97:4:514-518. 
  118. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005; 143:10:697-706. 
  119. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium — a register-based case-control study. Am J Obs Gynecol. United States. 2008;198:2:233.e1-7. 
  120. Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C, Priollet P, Cohen C, Yvelin N, Schved JF, Tournaire M, Borg JY. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG. England. 2001;108:11:1134-1140.
  121. Pettilä V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb. Haemost. Germany. 2002;87:2:182-186. 
  122. Carlin AJ, Farquharson RG, Quenby SM, Topping J, Fraser WD. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control. Hum Reprod. England. 2004;19:5:1211-1214.
  123. Rodger MA, Kahn SR, Cranney A, Hodsman A, Kovacs MJ, Clement AM, Lazo-Langner A, Hague WM. Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost. England. 2007;5:8:1600-1606.
  124. Byrd LM, Shiach CR, Hay CRM, Johnston TA. Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated? J Obs Gynaecol. England. 2008;28:5:539-542. 
  125. Le Templier G, Rodger MA. Heparin-induced osteoporosis and pregnancy. Curr Opin Pulm Med. United States. 2008;14:5:403-407. 
  126. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJM. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. England. 2008;6:4:632-637. 
  127. Roach REJ, Lijfering WM, Van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR, Cannegieter SC. The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood. 2013;122:26:4264-4269.
  128. Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, Ageno W. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost. England. 2013;11:2:270-281. 
  129. Linnemann B, Scholz U, Rott H, Halimeh S, Zotz R, Gerhardt A, Toth B, Bauersachs R. Treatment of pregnancy-associated venous thromboembolism — position paper from the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH). Vasa. 2016;45:2:103-118. 
  130. Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, Brenner B, Dulitzky M, Nielsen JD, Boda Z, Turi S, Mac Gillavry MR, Hamulyák K, Theunissen IM, Hunt BJ, Büller HR. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost. Germany. 1999;81:5:668-672. 
  131. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. United States. 1995;332:20:1330-1335.
  132. Weitz JI. Low-molecular-weight heparins. N Engl J Med. United States. 1997;337:10:688-698. 
  133. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. United States. 2005;106:2:401-407. 
  134. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obs Gynecol Obstet Gynecol. 2018;132:1:1-17. 
  135. Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, Ageno W. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost. England. 2013;11:2:270-281. 
  136. Jacobson B, Rambiritch V, Paek D, Sayre T, Naidoo P, Shan J, Leisegang R. Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. Adv Ther. 2020;37:1:27-40. 
  137. Anticoagulation in Pregnancy and Lactation. Precis. Anticoagulation Med. Ed. Goubran H., Ragab G., Hassouna S. Springer Nature. 2020;147-157. 
  138. Tang A-W, Greer I. A systematic review on the use of new anticoagulants in pregnancy. Obs Med. 2013;6:2:64-71. 
  139. Bapat P, Pinto LSR, Lubetsky A, Berger H, Koren G. Rivaroxaban transfer across the dually perfused isolated human placental cotyledon. Am J Obs Gynecol. United States. 2015;213:5:710.e1-6. 
  140. Nakhai-Pour HR, Broy P, Sheehy O, Bérard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ. 2011;183:15:1713-1720.
  141. Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322:7281:266-270. 
  142. Stergiakouli E, Thapar A, Davey Smith G. Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding. JAMA Pediatr. 2016;170:10:964-970. 
  143. Nielsen GL, Skriver MV, Pedersen L, Sørensen HT. Danish group reanalyses miscarriage in NSAID users. BMJ. 2004;328:7431:109. 
  144. Li D-K, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003;327:7411:368. 
  145. Edwards DRV, Aldridge T, Baird DD, Funk MJ, Savitz DA, Hartmann KE. Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion. Obs Gynecol. 2012;120:1:113-122. 
  146. MHRA Medicines and Health Regulatory Agency. MHRA Drug Safety Update [Electronic resource]. 2015. 2020. Accessed: 09.10.20.  https://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate
  147. Rigourd V, de Villepin B, Amirouche A, Bruneau A, Seraissol P, Florent A, Urien S, Magny J-F, Serreau R. Ibuprofen concentrations in human mature milk--first data about pharmacokinetics study in breast milk with AOR-10127 «Antalait» study. Ther Drug Monit. United States. 2014;36:5:590-596. 
  148. Stanley AY, Durham CO, Sterrett JJ, Wallace JB. Safety of Over-the-Counter Medications in Pregnancy. MCN Am J Matern Child Nurs. United States. 2019;44:4:196-205. 
  149. New FDA Pregnancy Categories Explained [Electronic resource]. 2015. Accessed: 09.10.20.  https://www.drugs.com/pregnancy-categories.html
  150. Briggs G, Freeman R. Acetaminophen. Drugs Pregnancy Lact. A Ref. Guid. to Fetal Neonatal Risk. 11th ed. Philadelphia: Wolters Kluwer Health; 2017;66-74. 
  151. Roberge S, Giguère Y, Villa P, Nicolaides K, Vainio M, Forest J-C, von Dadelszen P, Vaiman D, Tapp S, Bujold E. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol. United States. 2012;29:7:551-556. 
  152. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D’Alton M, Berghella V, Nicolaides KH, Hod M. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obs. 2019;145(suppl):Suppl 1:1-33. 
  153. US Food and Drug Administration, Title 21 — Food and Drugs, chapter «I» — Food and Drug administration, department of health and human services, Subchapter «D» — Drugs for human use, Part 341-343 [Electronic resource]. 2015. Accessed: 17.10.20.  https://www.law.cornell.edu/cfr/text/21/chapter-I/subchapter-D
  154. Datta P, Rewers-Felkins K, Kallem RR, Baker T, Hale TW. Transfer of Low Dose Aspirin Into Human Milk. J Hum Lact. United States. 2017;33:2: 296-299. 
  155. World Health Organization, UNICE. Breastfeeding and maternal medication. Recommendations for drugs in the eleventh WHO model list of essential drugs. 2002;35. 
  156. Flessa HC, Kapstrom AB, Glueck HI, Will JJ. Placental transport of heparin. Am J Obs Gynecol. United States. 1965;93:4:570-573. 
  157. Clark NP, Delate T, Witt DM, Parker S, McDuffie R. A descriptive evaluation of unfractionated heparin use during pregnancy. J Thromb Thrombolysis. Netherlands. 2009;27:3:267-273. 
  158. Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R. Heparin therapy during pregnancy. Risks to the fetus and mother. Arch Intern Med. United States. 1989;149:10:2233-2236.
  159. Streiff MB, et al. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 21.2020. J Natl Compr Canc Netw. United States. 2020.
  160. Galanaud J-P, Blaise S, Sevestre M-A, Terrisse H, Pernod G, Gaillard C, Genty C, Monreal M, Rabah Y, Kahn SR, Quéré I, Bosson J-L. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer. Thromb Res. United States. 2018;171:179-186. 
  161. Ploton, Pistorius, Raimbeau, Denis Le Seve, Bergère, Ngohou, Goueffic, Artifoni, Durant, Gautier, Connault, Espitia. A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis. Med Medicine (Baltimore). 2020;99:6. 
  162. Chen P, Zhu B, Wan G, Qin L. The incidence of asymptomatic thrombosis related to peripherally inserted central catheter in adults: A systematic review and meta‐analysis People’s. Nurs Open. Nurs Open. 2021. Online ahead of print.
  163. Somonova OV, Antukh EA, Dolgushin BI, Elizarova AL, Selchuk VY, Cherkasov VA. Practical recommendations for the prevention and treatment of thromboembolic complications in cancer patients. Malignant tumors : Practical recommendations RUSSCO. #3s2. 2019;9:668-677. (In Russ.).
  164. Sushinskaya TV, Stuklov NI, Dobrohotova UE. Hemostasis and cancer-associated thrombosis: modern prevention and treatment. Oncology. Journal named after. P.A. Herzen. 2018;7:4:64-72. (In Russ.).
  165. Pustovoyt A, Gavrilov SG, Zolotukhin IA. Treatment tactics for acute ascending thrombophlebitis. Phlebology. 2011;5:46-52.  (In Russ.).
  166. Wang G, Li Y, Wu C, Guo L, Hao L, Liao H, Xiao X, Liu S, Luo L. The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: A prospective study. Medicine (Baltimore). 2020;99:12:e19409.
  167. Dammacco F, Vacca A, Procaccio P, Ria R, Marech I, Racanelli V. Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med. 2013;13:2:85-97. 
  168. Mate-Kole MO, Nkrumah K. Thrombophlebitis migrans as a marker of malignancy. East Afr Med J. 1986;63:9:610-612. 
  169. Vorobyov AV, Makatsaria AD, Chabrov AM, Savchenko AA. Trusso syndrome: a modern view of the problem. Journal of Obstetrics and Women's Diseases. 2015;64:4:85-94.  (In Russ.).
  170. Fazeli B, Modaghegh H, Ravrai H, Kazemzadeh G. Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective-descriptive study in north-east of Iran. Clin Rheumatol. 2008;27:1:55-57. 
  171. Zerbino D, Zimba E, Bagrii N. Obliterating thrombangiitis (Buerger's disease): the current state of the problem. Angiology and vascular surgery. 2016;22:4:390-395. (In Russ.).
  172. Mondor H. Tronculite sous-cutanée subaiguë de la paroi thoraccique antero-laterale. Mem Acad Chir. 1939;65:1271-1278.
  173. Cervellin G, Creta M, Riva M, Di Comite V, Buttarelli L, Lippi G. Abdominal Mondor’s disease presenting as acute abdominal pain. Acta Biomed. 2013;84:2:155-158. 
  174. Hou MF, Huang CJ, Huang YS, Hsieh JS, Chan HM, Wang JY, Chuang CH, Chen FM, Huang TJ. Mondor’s disease in the breast. Kaohsiung J Med Sci. 1999;15:11:632-639. 
  175. Pasta V, D’Orazi V, Sottile D, Del Vecchio L, Panunzi A, Urciuoli P. Breast Mondor’s disease: Diagnosis and management of six new cases of this underestimated pathology. Phlebology. 2015;30:8:564-568. 
  176. Pugh CM, DeWitty RL. Mondor’s disease. J Natl Med Assoc. 1996;88:6: 359-363. 
  177. Amano M, Shimizu T. Mondor’s Disease: A Review of the Literature. Intern Med. Intern Med. 2018;57:18:2607-2612.
  178. Scovell SD, Ergul EA, Conrad MF. Medical management of acute superficial vein thrombosis of the saphenous vein. J Vasc Surg Venous Lymphat Disord. 2017.
  179. Ruben, Wouter, Jorn, Reinold, Karina, Frederik, Horst V. Der, Iwan. Intermediate Dose Low-Molecular-Weight Heparin for Thrombosis Prophylaxis: Systematic Review with Meta-Analysis and Trial Sequential Analysis. Semin Thromb Hemost. 2019;45:8:810-824. 
  180. Belcaro G, Nicolaides AN, Errichi BM, Cesarone MR, Sanctis MT, De Incandela L, Venniker R, Belcaro G. Superficial Thrombophlebitis of the Legs: A Randomized, Controlled, Follow-up Study. Angiology. 1999;50:7:523-529. 
  181. Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA, INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism). Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation. 2014;130:13:1062-1071.
  182. Weitz JI, et al. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med. 2017;376,:13:1211-1222.
  183. Messa G, La Placa G, Puccetti L, Di Perri T. Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide. Minerva Cardioangiol. 1997;45:4:147-153. 
  184. Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, Pawlaczyk-Gabriel K, Džupina A, Sokurenko GY, Didenko YP, Andrei LD, Lessiani G, Visonà A. Sulodexide for the prevention of recurrent venous thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) study: A multicenter, randomized, double-blind, placebo-controlled trial. Circulation. 2015;132:20:1891-1897.
  185. Paraskevas KI, Nicolaides AN, Mikhailidis DP. Statins and venous thromboembolism: the jury is still out. Angiology. 2013;64:7:489-491. 
  186. Enas EA, Kuruvila A, Khanna P, Pitchumoni CS, Mohan V. Benefits vs risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians — a population with the highest risk of premature coronary artery disease & diabetes. Indian J Med Res. 2013;138:4:461-491. 
  187. Squizzato A, Galli M, Romualdi E, Dentali F, Kamphuisen PW, Guasti L, Venco A, Ageno W. Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Hear J. 2010;31:10:1248-1256.
  188. Kunutsor SK, Seidu S, Khunti K. Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies. Eur Hear J. 2017;38:20:1608-1612.
  189. Sheikh P, Lohsiriwat V, Shelygin Y. Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis. Adv Ther. 2020;37:6:2792-2812.
  190. Nocker W, Diebschlag W, Lehmacher W. The efficacy of a diclofenac gel compared with placebo and heparin gel in the local treatment of superficial thrombophlebitis. Z Allg Med. 1991;67:2214-2222.
  191. Winter W, Klotten K, Arnold S, Babiak D, Stoinder B. Local therapy of thrombophlebitis-superficialis-an interindividual comparison of voltaren emulgel versus a heparin-containing gel. Z Rheumatol. 1986;45:4:180-181. 
  192. Holzgreve A, Kleine W, Stegmann W. Local treatment of superficial thrombophlebitis with nonsteroidal antiinflammatory agents. ZFA. 1989;65:27: 663-667. 
  193. Kurginyan KM, Raskin VV. Endovascular treatment of acute thrombophlebitis of lower limb veins in patients with varicose veins disease. Surgery. Journal of N.I. Pirogov. N.I. Pirogov. 2019;10:50-54. (In Russ.).
  194. Shabunin A, Gavrilov S, Pustovoit S, Bychkova T, Karalkin A, Zolotukhin I. Comparison of the effectiveness of surgical and conservative tactics in acute ascending varicotrombophlebitis of the great saphenous vein of the thigh. Phlebology. 2013;7:2:10-14. (In Russ.).
  195. Schwalb P, Kaczynski A, Narizny M. Phlebocentesis - a minimally invasive method of treatment of acute saphenous vein thrombophlebitis. Phlebology. 2009;3:3:23-25. (In Russ.).
  196. Enzler MA, Russell D, Schimmelpfennig J. Thermal ablation in the management of superficial thrombophlebitis. Eur J Vasc Endovasc Surg. England. 2012;43:6:726-728. 
  197. Gradman WS. Endovenous saphenous vein ablation in patients with acute isolated superficial-vein thrombosis. Phlebology. 2015;30:3:204-209. 
  198. Figueiredo, Stansby, Bhattacharya. Primary prevention of venous thromboembolism. Phlebology. Phlebology. 2012;27(suppl 2):suppl 2:23-32. 
  199. Chang SL, Huang YL, Lee MC, Hu S, Hsiao YC, Chang SW, Chang CJ, Chen PC. Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease. JAMA. JAMA. 2018;319:8:807-817. 
  200. Clarke M, Hopewell S, Juszczak E, Eisinga A, Kjeldstrøm M. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database of Systematic Reviews. 2016;9:50. 
  201. Galanaud J-P, Sevestre M-A, Pernod G, Kahn SR, Genty C, Terrisse H, Brisot D, Gillet J-L, Quéré I, Bosson J-L. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis. J Thromb Haemost. England. 2017;15:6:1123-1131.
  202. Jiang QJ, Bai J, Jin J, Shi J, Qu L. Sulodexide for secondary prevention of recurrent venous thromboembolism: A systematic review and meta-analysis. Front Pharmacol. 2018;9:876. 
  203. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367:21:1979-1987.
  204. Wang KL, van Es N, Cameron C, Castellucci LA, Büller HR, Carrier M. Extended treatment of venous thromboembolism: a systematic review and network meta-analysis. Heart. Heart. 2019;105:7:545-552. 
  205. Vasanthamohan L, Boonyawat K, Chai-Adisaksopha C, Crowther M. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost. J Thromb Haemost. 2018;16:7:1288-1295.
  206. Camporese G, Bernardi E, Noventa F. Update on the clinical use of the low-molecular-weight heparin, parnaparin. Vasc Heal. Risk Manag. 2009;5:819-831. 
  207. Mitić G, Kovac M, Povazan L, Djordjević V, Ilić V, Salatić I, Lazić R, Antonijević N, Novakov-Mikić A. Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium. Srp Arh Celok Lek. Srp Arh Celok Lek. 2010;138(suppl):18-22. 
  208. Bleker SM, et al. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses. Thromb Res. Thromb Res. 2016;144:62-68. 
  209. Maggio L. Medications for Pregnant Women With Obesity: Special Considerations. Clin Obstet Gynecol. Clin Obstet Gynecol. 2021;64:1:214-225. 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.